ATTONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Attovia Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Sep 2, 2026
$13.89+0.16 (+1.17%)
Close on Oct 19, 2026
- Market cap
- $58.86M
- P/E (TTM)
- –
- Dividend yield
- –
About Attovia Therapeutics
Biological Products, (No Diagnostic Substances), SIC 2836
Attovia Therapeutics, Inc. is listed on Nasdaq under the ticker ATTO, in the SEC industry Biological Products, (No Diagnostic Substances). It is incorporated in Delaware and its fiscal year ends on December 31. Reported financials on StockData start in fiscal 2024.
Company profile
Company
- Legal name
- Attovia Therapeutics, Inc.
- Headquarters
- San Carlos, CA
- Address
- 1091 Industrial Road 94070
- Phone
- (510) 399-5001
- Website
- attovia.com
- Industry
- Biological Products, (No Diagnostic Substances)
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
Stock & identifiers
- Ticker
- ATTO
- Exchange
- Nasdaq
- IPO date
- Aug 5, 2026
- Shares outstanding
- 46M, Aug 31, 2026
- Filer category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- SEC CIK
- 2058707
- CUSIP
- 04987L102
- ISIN
- US04987L1026
- EIN
- 92-1510574
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Attovia Therapeutics, Inc. | President and CEO, Director | 449,371 |
| Hubert Chen | Chief Medical Officer | 2,960 |
| Zaneta Odrowaz | Chief Business Officer | 103,269 |
| Petter Veiby | Chief Scientific Officer | 104,951 |
| Colin Walsh | Director | 2,520,632 |
| Mitchell Gold | Director | – |
| Angie You | Director | 52,852 |
| John W. Smither | Director | – |
| James N. Topper | Director | – |
| Aaron Royston | Director | – |
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Aug 5, 2026 | IPO | Initial public offering priced (424B4 prospectus) |
| Jul 29, 2026 | Listing | Registration of securities on an exchange (Form 8-A) |